Skip to main content

Author: Craig Boerner

Dolly Parton donates $1 million to pediatric infectious disease research at Vanderbilt University Medical Center

Jun. 15, 2022—Dolly Parton is donating $1 million to pediatric infectious disease research at Vanderbilt University Medical Center to help in the fight against serious infectious diseases such as coronavirus that have worldwide ramifications.

Read more


Trauma study aims to improve survival for bleeding patients

Jun. 1, 2022—Emergency Medicine and Trauma Surgery researchers at Vanderbilt University Medical Center are joining Vanderbilt LifeFlight in a Department of Defense (DOD)-funded clinical trial aimed at improving survival with resuscitation techniques used to keep patients alive after a traumatic injury.

Read more


Care access pathways similar for young Black and white athletes in concussion network

Apr. 28, 2022—Vanderbilt research found that both Black and white young athletes who suffered concussions while within a sport-related concussion (SRC) clinic referral did not experience health disparities related to their care.

Read more


Study shows young, healthy adults died from COVID-19 due to ECMO shortage

Feb. 25, 2022—Vanderbilt research found that nearly 90 percent of COVID-19 patients who qualified for, but did not receive, ECMO due to a shortage of resources during the height of the pandemic died in the hospital, despite being young with few other health issues

Read more


Study shows life-saving benefit of baricitinib for ventilated COVID patients

Feb. 7, 2022—Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.

Read more


Study finds shorter treatment better for young children with outpatient pneumonia

Feb. 3, 2022—A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.

Read more


Potential Rett syndrome drug shows promising results in phase 3 trial

Dec. 6, 2021—A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.

Read more


Case to depart role as Chief Compliance Officer

Nov. 17, 2021—Vanderbilt University Medical Center Chief Compliance Officer Edward (Ted) Case, JD, is leaving VUMC to return to private law practice.

Read more


Raman, Balucan receive health equity research grants

Sep. 9, 2021—Vanderbilt researchers Rameela Raman, PhD, and Francis Balucan, MD, MBA, are the recipients of the first annual Vanderbilt Center for Health Services Research (CHSR) Health Equity Research Grants.

Read more


VUMC, NIH launch clinical trial to test novel therapies to protect host tissue against COVID-19

Jul. 26, 2021—Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

Read more


COVID-19 pandemic brought changes in cigarette smoking: study

Jun. 9, 2021—Smokers who believed they were at increased risk of getting COVID-19 during the pandemic, or having a more severe case, were more likely to quit while those whoperceived more stress increased smoking, according to new research published in the Journal of General Internal Medicine.

Read more


Type 2 diabetes medication shown to benefit asthma patients

May. 20, 2021—Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more